Zusammenfassung
In den letzten Jahren tritt der Diabetes mellitus Typ 2 nahezu epidemisch auf. Weltweit sind mehr als 170 Millionen Menschen betroffen, allein in Deutschland leben ˜ 6 Millionen Erkrankte. In der Pathogenese des Typ-2-Diabetes spielt die Kombination aus Insulinresistenz von Fettgewebe, Muskulatur und Leber mit einem zunehmenden Insulinsekretionsdefekt der pankreatischen β-Zelle eine zentrale Rolle. Dabei sind sowohl genetische Faktoren als auch Umwelteinflüsse entscheidend an der Entstehung eines Typ-2-Diabetes beteiligt, wobei die genauen pathogenetischen Mechanismen noch weitgehend unbekannt sind. Zur Beurteilung der Bedeutung von Muskulatur, Leber und Fettgewebe bei der Ausprägung des Typ-2-Diabetes hat die Generierung gewebespezifischer Insulinrezeptor-Knockout-Mausmodelle wesentlich zum Verständnis der Rolle dieser Organe der Insulinresistenz beigetragen.
Summary
In the last years type 2 diabetes has reached almost epidemic proportions. More than 170 million individuals are affected worldwide, about ˜ 6 million in Germany. In the pathogenesis of type 2 diabetes, insulin resistance in liver, fat and muscle as well as the inability of the pancreatic β-cell to fully compensate for this insulin resistance are the central pathophysiological events. Both genetic and environmental factors, such as lack of physical exercise and hypercaloric nutrition play a major role in this process, although the precise mechanisms for type 2 diabetes development remain largely unknown. In the characterization of the role of liver, adipose tissue and skeletal muscle in the pathogenesis of type 2 diabetes, tissue specific knockout mouse models have challenged our concepts of glucose homeostasis.
Literatur
-
1
Abel E D, Peroni O D, Kim J K. et al .
Adipose-selective targeting of the GLUT4 gene impaires insulin action in muscle and liver.
Nature.
2001;
409
729-733
-
2
Accili D, Drago J, Lee E J. et al .
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.
Nat Genet.
1996;
12
106-109
-
3
Barzilai N, She L, Liu B Q. et al .
Surgical removal of visceral fat reverses hepatic insulin resistance.
Diabetes.
1999;
48
94-98
-
4
Blüher M, Paschke R.
Visceral adipose tissue and metabolic syndrome.
Dtsch Med Wochenschr.
2003;
128
2319-2323
-
5
Blüher M, Michael M D, Peroni O D. et al .
Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.
Dev Cell.
2002;
3
25-38
-
6
Blüher M, Kahn B B, Kahn C R.
Extended longevity in mice lacking the insulin receptor in adipose tissue.
Science.
2003;
299
572-574
-
7
Brüning J C, Gautam D, Burks D J. et al .
Role of brain insulin receptor in control of body weight and reproduction.
Science.
2000;
289
2122-2125
-
8
Brüning J C, Michael M D, Winnay J N. et al .
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
Mol Cell.
1998;
2
559-569
-
9
DeFronzo R A.
Pathogenesis of type 2 Diabetes: Metabolic and molecular implications for identifying diabetes genes.
Diabetes Rev.
1997;
5
177-269
-
10
Eckel R H, Grundy S M, Zimmet P Z.
The metabolic syndrome.
Lancet.
2005;
365
1415-1428
-
11
Esposito K, Marfella R, Ciotola M. et al .
Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.
JAMA.
2004;
92
1440-1446
-
12
Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G.
Insulin resistance and hypersecretion in obesity.
J Clin Invest.
1997;
100
1166-1173
-
13
Foley J E.
Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus.
Diab Care.
1992;
15
773-784
-
14
Frayn K N.
Visceral fat and insulin resistance - causative or correlative?.
Br J Nutr.
2000;
83
S71-S77
-
15
Gu H, Marth J D, Orban P C, Mossmann H, Rajewski K.
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.
Science.
1994;
265
103-106
-
16
Jacob S, Machann J, Rett K. et al .
Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
Diabetes.
1999;
48
1113-1119
-
17
James D E, Burleigh K M, Kraegen E W.
Time dependence of insulin action in muscle and adipose tissue in the rat in vivo: An increasing response in adipose tissue with time.
Diabetes.
1985;
34
1049-1054
-
18
Jansson P -A, Larsson A, Smith U, Lonnroth P.
Lactate release from the subcutaneous tissue in lean and obese men.
J Clin Invest.
1994;
93
240-246
-
19
Joffe B I, Panz V R, Raal F J.
From lipodystrophy syndromes to diabetes mellitus.
Lancet.
2001;
357
1379-1381
-
20
Kahn C R.
Insulin action, diabetogenes, and the cause of type II diabetes (Banting Lecture).
Diabetes.
1994;
43
1066-1084
-
21
Kashiwagi A, Verso M A, Andrews J, Vasques G, Reaven G, Foley J E.
In vitro insulin resistance of human adipocytes isolated from subjects with non-insulin-dependent diabetes mellitus.
J Clin Invest.
1983;
72
1246-1254
-
22
Kiens B.
Skeletal muscle lipid metabolism in exercise and insulin resistance.
Physiol Rev.
2006;
86
205-243
-
23
Kim J K, Zisman A, Fillmore J J. et al .
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
J Clin Invest.
2001;
108
153-160
-
24
King H, Aubert R E, Hermann W H.
Global burden of diabetes, 1995 - 2025: prevalence, numerical estimates, and projections.
Diabetes Care.
1998;
21
1414-1431
-
25
Klein S, Fontana L, Young V L. et al .
Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
N Engl J Med.
2004;
350
2549-2557
-
26
Kopelman P G.
Obesity as a medical problem.
Nature.
2000;
404
635-643
-
27
Kovacs P, Stumvoll M.
Fatty acids and insulin resistance in muscle and liver.
Best Pract Res Clin Endocrinol Metab.
2005;
19
625-635
-
28
Kulkarni R N, Brüning J C, Winnay J N, Postic C, Magnuson M A, Kahn C R.
Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes.
Cell.
1999;
96
329-339
-
29
Krssak M, Falk Petersen K, Dresner A. et al .
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.
Diabetologia.
1999;
42
113-116
-
30
LaMonte M J, Barlow C E, Jurca R, Kampert J B, Church T S, Blair S N.
Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women.
Circulation.
2005;
112
505-512
-
31
Martin B C, Warram J H, Krolewski A S, Bergmann R N, Soeldner J S, Kahn C R.
Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a 25-year follow-up study.
Lancet.
1992;
340
925-929
-
32
Matthaei S, Stumvoll M, Kellerer M, Häring H U.
Pathophysiology and pharmacological treatment of insulin resistance.
Endocr Rev.
2000;
21
585-618
-
33
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G.
Use of metabolic markers to identify overweight individuals who are insulin resistant.
Ann Intern Med.
2003;
139
802-809
-
34
Meigs J B, Mittleman M A, Nathan D M. et al .
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
JAMA.
2000;
283
221-228
-
35
Meigs J B.
Metabolic syndrome and risk for type 2 diabetes.
Exp Rev Endocrinol Metab.
2006;
1
57-66
-
36
Michael M D, Kulkarni R N, Postic C. et al .
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
Mol Cell.
2000;
6
87-97
-
37
Mitrakou A, Kelley D, Mokan M. et al .
Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
N Engl J Med.
1992;
326
22-29
-
38
Palitzsch A D, Nusser J, Arndt H. et al., Diabetomobil-Studiengruppe .
Die Prävalenz des Diabetes mellitus wird in Deutschland deutlich unterschätzt - eine bundesweite epidemiologische Studie auf der Basis einer HbA1c-Analyse.
Diab Stoffw.
2000;
8
189-200
-
39
Reaven G M.
Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes.
1988;
37
1595-1607
-
40
Reaven G M.
Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.
Cell Metab.
2005;
1
9-14
-
41
Stumvoll M, Goldstein B J, van Haeften T W.
Type 2 diabetes: principles of pathogenesis and therapy.
Lancet.
2005;
365
1333-1346
-
42
Stumvoll M.
Glukosehomöostase.
Dtsch med Wochenschr.
1997;
122
235-241
-
43
Taylor S I, Cama A, Accili D. et al .
Mutations in the insulin receptor gene.
Endocr Rev.
1992;
13
566-595
-
44
Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P.
A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding.
Int J Obes Relat Metab Disord.
2002;
26
193-199
-
45
Wajchenberg B L.
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.
Endocrine Reviews.
2000;
21
697-738
-
46
Zimmet P, Alberti K G, Shaw J.
Global and societal implications of the diabetes epidemic.
Nature.
2001;
414
782-787
Prof. Dr. med. Matthias Blüher
Universität Leipzig, Medizinische Klinik und Poliklinik III
Philipp-Rosenthal-Straße 27
04103 Leipzig
Phone: 0341/9713380
Fax: 0341/9713389
Email: bluma@medizin.uni-leipzig.de
